Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 172

1.
2.

Lacking effect of grapefruit juice on theophylline pharmacokinetics.

Fuhr U, Maier A, Keller A, Steinijans VW, Sauter R, Staib AH.

Int J Clin Pharmacol Ther. 1995 Jun;33(6):311-4.

PMID:
7582380
3.

Naringin and naringenin are not the primary CYP3A inhibitors in grapefruit juice.

Edwards DJ, Bernier SM.

Life Sci. 1996;59(13):1025-30.

PMID:
8809221
4.

The fate of naringin in humans: a key to grapefruit juice-drug interactions?

Fuhr U, Kummert AL.

Clin Pharmacol Ther. 1995 Oct;58(4):365-73.

PMID:
7586927
5.

Grapefruit-felodipine interaction: effect of unprocessed fruit and probable active ingredients.

Bailey DG, Dresser GK, Kreeft JH, Munoz C, Freeman DJ, Bend JR.

Clin Pharmacol Ther. 2000 Nov;68(5):468-77.

PMID:
11103749
6.
7.

In vitro inhibition of simvastatin metabolism in rat and human liver by naringenin.

Ubeaud G, Hagenbach J, Vandenschrieck S, Jung L, Koffel JC.

Life Sci. 1999;65(13):1403-12.

PMID:
10503959
8.

Grapefruit juice-felodipine interaction: effect of naringin and 6',7'-dihydroxybergamottin in humans.

Bailey DG, Kreeft JH, Munoz C, Freeman DJ, Bend JR.

Clin Pharmacol Ther. 1998 Sep;64(3):248-56.

PMID:
9757148
9.

Effects of antidepressant drugs on the activity of cytochrome P-450 measured by caffeine oxidation in rat liver microsomes.

Danie WA, Syrek M, Ryłko Z, Wójcikowski J.

Pol J Pharmacol. 2001 Jul-Aug;53(4):351-7.

10.

The character of inhibition of the metabolism of 1,2-benzopyrone (coumarin) by grapefruit juice in human.

Runkel M, Bourian M, Tegtmeier M, Legrum W.

Eur J Clin Pharmacol. 1997;53(3-4):265-9.

PMID:
9476043
11.
12.

Inhibition of dihydropyridine metabolism in rat and human liver microsomes by flavonoids found in grapefruit juice.

Miniscalco A, Lundahl J, Regårdh CG, Edgar B, Eriksson UG.

J Pharmacol Exp Ther. 1992 Jun;261(3):1195-9.

PMID:
1602384
13.

Effects of grapefruit juice and smoking on verapamil concentrations in steady state.

Fuhr U, Müller-Peltzer H, Kern R, Lopez-Rojas P, Jünemann M, Harder S, Staib AH.

Eur J Clin Pharmacol. 2002 Apr;58(1):45-53. Epub 2002 Mar 15.

PMID:
11956673
14.

Content of CYP3A4 inhibitors, naringin, naringenin and bergapten in grapefruit and grapefruit juice products.

Ho PC, Saville DJ, Coville PF, Wanwimolruk S.

Pharm Acta Helv. 2000 Apr;74(4):379-85.

PMID:
10812937
15.

Bergamottin, lime juice, and red wine as inhibitors of cytochrome P450 3A4 activity: comparison with grapefruit juice.

Bailey DG, Dresser GK, Bend JR.

Clin Pharmacol Ther. 2003 Jun;73(6):529-37.

PMID:
12811362
17.

Naringin is a major and selective clinical inhibitor of organic anion-transporting polypeptide 1A2 (OATP1A2) in grapefruit juice.

Bailey DG, Dresser GK, Leake BF, Kim RB.

Clin Pharmacol Ther. 2007 Apr;81(4):495-502. Epub 2007 Feb 14.

PMID:
17301733
18.

Interaction of pefloxacin and enoxacin with the human cytochrome P450 enzyme CYP1A2.

Kinzig-Schippers M, Fuhr U, Zaigler M, Dammeyer J, Rüsing G, Labedzki A, Bulitta J, Sörgel F.

Clin Pharmacol Ther. 1999 Mar;65(3):262-74.

PMID:
10096258
19.

Inhibition of human breast cancer cell proliferation and delay of mammary tumorigenesis by flavonoids and citrus juices.

So FV, Guthrie N, Chambers AF, Moussa M, Carroll KK.

Nutr Cancer. 1996;26(2):167-81.

PMID:
8875554
20.

Inhibition of human CYP3A4 activity by grapefruit flavonoids, furanocoumarins and related compounds.

Ho PC, Saville DJ, Wanwimolruk S.

J Pharm Pharm Sci. 2001 Sep-Dec;4(3):217-27.

Items per page

Supplemental Content

Write to the Help Desk